Virological failure among patients on HAART from across Europe: Results from the EuroSIDA study

Antiviral Therapy

Volumn 5, Issue 2, 2000, Pages 107-112

  Mocroft, A ^a   Miller, V ^b   Chiesi, A ^c   Blaxhult, A ^d   Katlama, C ^e   Clotet, B ^f   Barton, S ^g   Lundgren, Jens D ^h  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Zentrum der Inneren Medizin   (Germany)

^c Lstituto Superiore di Sanita   (Italy)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^h HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ARTICLE; EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; EUROPE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 0033878926     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN & Lundgren JD. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352:1725-1730.
2. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P & Battegay M. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. British Medical Journal 1997; 315:1194-1199.
3. Carpenter CCJ, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG & Volberding PA. Antiretroviral therapy in adults: Updated recommendations of the International AIDS society - USA panel. Journal of the American Medical Association 2000; 283:381-390.
4. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Freiberg JE, Balfour HH, Deyton LR, Chodakewitz JA & Fishl MA. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimetre or less. New England Journal of Medicine 1997; 337:725-733.
5. Paredes R, Mocroft A, Kirk O, Lazzarin A, Barton SE, van Lunzen J, Katzenstein TL, Antones F, Lundgren JD & Clotet B. Predictors of virological success and ensuing failure among HIV+ patients starting HAART in Europe: Results from the EuroSIDA study. Archives of Internal Medicine 2000; 160:1123-1132.